MetaCap

Arrowhead Pharmaceuticals (ARWR) vs Veradermics (MANE)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Arrowhead Pharmaceuticals is the larger company by market cap ($5.85 billion vs $5.04 billion), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ARWR-39.22%MANE+216.61%
+332%+138%-57%
Feb 4, 20261 yearNov 20, 2026
ARWR-35.88%MANE+210.60%
+278%+114%-51%
Feb 2, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ARWR versus MANE key metrics
MetricARWRMANE
Share price$41.37$119.52
Market cap$5.85B$5.04B
1-day change-5.22%-3.92%
YTD return-37.69%—
1-year return+2.27%—
5-year return-42.56%—
EPS (TTM)$-5.11$-3.89
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$450.82M—
Revenue growth (YoY)-45.65%—
Net income (latest FY)$-724.21M$-70.00M
Operating margin-156.86%—
Net margin-160.64%—
52-week high$95.49$156.63
52-week low$40.43$32.00
Distance from 52-week high-56.68%-23.69%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+156.39%+56.74%
Average volume2.08M738.22K
Shares outstanding141.37M42.20M
Employees1,06251
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Arrowhead Pharmaceuticals

ARWR stock →

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 1,062 employees

About Veradermics

MANE stock →

Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children.

Health Care · Biotechnology: Pharmaceutical Preparations · 51 employees

ARWR vs MANE FAQ

Which is bigger, Arrowhead Pharmaceuticals or Veradermics?

Arrowhead Pharmaceuticals (ARWR) is larger, with a market capitalization of $5.85B compared with $5.04B for Veradermics (MANE).

Are Arrowhead Pharmaceuticals and Veradermics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons